Natco to recall nanotech anticancer in India
This article was originally published in Scrip
Executive Summary
The drugs controller general of India (DCGI) has ordered a recall of Natco Pharma's breast cancer drug, Albupax (paclitaxel in an albumin bound nano-particle form) over concerns that the product may cause liver damage.